Atlas Trials

Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis

Clinical trial NCT03612856 · COMPLETED

Trial details

NCT number
NCT03612856
Sponsor
Aronora, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
End Stage Renal DiseaseThrombosis
Start date
2018-10-29
Primary completion
2019-07-06
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.